New Omicron subvariant resistant to all antibody therapies: Indian-origin scientist - 1breakingnews.
1BN-RADIO
2022-11-24
Views 5
New Delhi, Nov 24 (SocialNews.XYZ) Omicron sub-lineage BQ.1.1, currently on the rise worldwide, is resistant to all approved antibody therapies, a new Lancet study led by an Indian-origin researcher has revealed. The researchers found that.
VIEW MORE : https://bit.ly/1breakingnews
VIEW MORE : https://bit.ly/1breakingnews
Report form
